ImmunoPrecise Antibodies Ltd. (HYFT) — Cash Flow Quality Index
ImmunoPrecise Antibodies Ltd. (HYFT) has a Cash Flow Quality Index of 0.11x as of October 2016. Operating cash flow of $11.17K is below net income of $101.16K, suggesting accrual-heavy earnings not yet converted to cash. Explore ImmunoPrecise Antibodies Ltd. (HYFT) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ImmunoPrecise Antibodies Ltd. Cash Flow Quality Index (2006–2016)
Historical Cash Flow Quality Index for ImmunoPrecise Antibodies Ltd. across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of ImmunoPrecise Antibodies Ltd. to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ImmunoPrecise Antibodies Ltd. (2006–2016)
Year-by-year earnings quality comparison for ImmunoPrecise Antibodies Ltd.. For live market cap and the full company financial profile, see market cap of ImmunoPrecise Antibodies Ltd..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | 1.88x | $284.09K | $151.03K | ▲ +380.3% |
| 2014 | -0.67x | $-46.60K | $69.44K | ▼ -1.0% |
| 2006 | -0.66x | $-110.59K | $166.48K | — |